The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Infections as a major preventable cause of human cancer
Open accessAbstract
Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183. Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many cancers arise from sites of infection, chronic irritation and inflammation.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Tumour cells produce various cytokines and chemokines that attract leukocytes.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“The Gram-negative bacterium H. pylori is established as a definite carcinogen for the development of gastric cancer — the second most common type of cancer globally11,29 — and DNA damage resulting from chronic inflammation is believed the mechanism32.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.bloodjournal503481 · Cited by 2,315
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodríguez, L. V., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich∥, N., Vogelman∥, J. H., & FRIEDMAN, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,826
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297
Research works printed but not linked: 12
- Parsonnet J., 1999, Microbes and Malignancy., 3
- Zur Hausen H., 1999, Microbes and Malignancy., 107
- IARC, Hepatitis viruses., 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
- Robinson WS., 1999, Microbes and Malignancy., 232
- Chung RT, 1999, Microbes and Malignancy., 267
- IARC, Infections with Epstein–Barr virus, human herpes viruses., 1997, IARC monographs on the evaluation of carcinogenic risks to humans., 70
- Pagona JS., 1975, Cold Spring Harbor Symposium on quantitative biology: tumor viruses, XXIX, 797
- Chang Y., 1999, Microbes and Malignancy., 207
- Newton R, 1999, Infections and Human Cancer., 237
- IARC. Schistosomes, Liver Flukes and Helicobacter Pylori., 1994, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 61.
- Danesh J., 1999, Infections and Human Cancer., 263
- EkströmA‐M.Factors related to the occurence of gastrric adenocarcinoma subtypes.Doctoral Dissertation Stockholm: Karolinska Institutet 2000.
Cited by
Sorted by citations
Items 201–300 of 738
Orlandi, E. M., Iacovelli, N. A., Tombolini, V., Rancati, T., Polimeni, A., Cecco, L. D., Valdagni, R., & Felice, F. D. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104453 · Cited by 60
Cervello, M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i30.4638 · Cited by 60
Anti-inflammatory and anti-tumor activity of the marine mangrove Rhizophora apiculata
Prabhu, V. V., & Guruvayoorappan, C. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.660997 · Cited by 60
Senescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 62
Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone
Cheng, W. Y., Huynh, H., Chen, P., Peña‐Llopis, S., & Wan, Y. (2016) · eLife · doi:10.7554/elife.18501 · Cited by 60
Can the Acute-Phase Reactant Proteins be Used as Cancer Biomarkers?
Pang, W. W., Abdul‐Rahman, P. S., Wan‐Ibrahim, W. I., & Hashim, O. H. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500101 · Cited by 59
Gibney, K. B., Mihrshahi, S., Torresi, J., Marshall, C. L., Leder, K. S., & Biggs, B. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.80.805 · Cited by 59
Giannitrapani, L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i16.2449 · Cited by 58
Cardio-oncology Related to Heart Failure
Blaes, A. H., Prizment, A. E., Koene, R. J., & Konety, S. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2016.12.006 · Cited by 63
Jiang, W., Chen, Y., Huang, J., Xi, D., Chen, J., Shao, Y., Xu, G., Ying, W., Wei, J., Chen, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19796 · Cited by 58
Shao, W., Fujiwara, N., Mouri, Y., Kisoda, S., Yoshida, K., Yoshida, K., Yumoto, H., Ozaki, K., Ishimaru, N., & Kudo, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-94384-1 · Cited by 58
Li, Y., Chang, S., Goldstein, B. Y., Scheider, W. L., Cai, L., You, N. Y., Tarleton, H. P., Ding, B., Zhao, J., Wu, M., et al. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.01.005 · Cited by 57
An IL-6 link between obesity and cancer
Ghosh, S. (2013) · Frontiers in Bioscience · doi:10.2741/e628 · Cited by 57
Pathogenic Role of Associated Adherent‐Invasive Escherichia coli in Crohn's Disease
Mazzarella, G., Perna, A., Marano, A., Lucariello, A., Aufiero, V. R., Sorrentino, A., Melina, R., Guerra, G., Taccone, F. S., Iaquinto, G., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25717 · Cited by 57
Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention
Irimie, A. I., Braicu, C., Paşca, S., Magdo, L., Gulei, D., Cojocneanu, R., Ciocan, C. A., Olariu, A., Coza, O. F., & Berindan‐Neagoe, I. (2019) · Medicina · doi:10.3390/medicina55060283 · Cited by 57
Tsuji, S., Kawai, N., Tsujii, M., Kawano, S., & Hori, M. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.18.s1.22.x · Cited by 57
Abdel‐Hamid, N. M., Abass, S. A., Mohamed, A. A., & Hamid, D. M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.104 · Cited by 56
Multiple Infections and Cancer: Implications in Epidemiology
Vedham, V., Divi, R. L., Starks, V. L., & Verma, M. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500366 · Cited by 56
Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice
Choi, Y. J., Choi, Y. J., Kim, N., Nam, R. H., Lee, S., Lee, H. S., Lee, H.-N., Surh, Y., & Lee, D. H. (2016) · Gut and Liver · doi:10.5009/gnl16068 · Cited by 55
Xu, X., Lei, Y., Chen, L., Zhou, H., Liu, H., Jiang, J., Yang, Y., & Wu, B. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02062-x · Cited by 55
Dermond, O., & Rüegg, C. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0219 · Cited by 56
Regulation of Cancer Cell Behavior by the Small GTPase Rab13
Ioannou, M. S., & McPherson, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.715193 · Cited by 53
Kozak, M. M., von Eyben, R., Pai, J., Anderson, E. M., Welton, M. L., Shelton, A. A., Kin, C., Koong, A. C., & Chang, D. T. (2015) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000183 · Cited by 53
The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer
Sahan, A. Z., Hazra, T. K., & Das, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00663 · Cited by 56
Association between Selected Oral Pathogens and Gastric Precancerous Lesions
Salazar, C. R., Sun, J., Li, Y., François, F., Corby, P. M. A., Perez-Perez, G., Dasanayake, A. P., Pei, Z., & Chen, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051604 · Cited by 52
Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer
Nihonyanagi, Y., Terai, K., Murano, T., Matsumoto, T., & Okazumi, S. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1085-4 · Cited by 52
Kapur, N., Mir, H., Clark, C. E., Krishnamurti, U., Beech, D. J., Lillard, J. W., & Singh, S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.113 · Cited by 52
The Rho-activating CNF1 toxin from pathogenic E. coli: A risk factor for human cancer development?
Travaglione, S., Fabbri, A., & Fiorentini, C. (2008) · Infectious Agents and Cancer · doi:10.1186/1750-9378-3-4 · Cited by 52
Li, C., Li, S., Jia, C., Yang, L., Song, Z., & Wang, Y. (2012) · Mediators of Inflammation · doi:10.1155/2012/248574 · Cited by 50
Hu, B., Elinav, E., & Flavell, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.12.16008 · Cited by 50
Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer
Pastille, E., Frede, A., McSorley, H. J., Gräb, J., Adamczyk, A., Kollenda, S., Hansen, W., Epple, M., Buer, J., Maizels, R. M., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006649 · Cited by 51
Inflammatory Cells in Diffuse Large B Cell Lymphoma
Tamma, R., Ranieri, G., Ingravallo, G., Annese, T., Oranger, A., Gaudio, F., Musto, P., Specchia, G., & Ribatti, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082418 · Cited by 51
Fiorino, S., Chili, E., Reggiani, M. L. B., Masetti, M., Deleonardi, G., Grondona, A. G., Silvestri, T., Magrini, E., Zanini, N., Cuppini, A., et al. (2013) · Pancreatology · doi:10.1016/j.pan.2013.01.005 · Cited by 50
Huang, Y., Zhang, J., Cui, Z., Zhao, J., & Ye, Z. (2012) · 癌症：英文版 · doi:10.5732/cjc.012.10063 · Cited by 50
The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study
Cotton, S. J., Belcher, J., Rose, P. W., Jagadeesan, S. K., & Neal, R. D. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.13 · Cited by 50
Physical Activity Before and After Diagnosis of Colorectal Cancer
Harriss, D., Cable, N. T., George, K., Reilly, T. P., Renehan, A. G., & Haboubi, N. Y. (2007) · Sports Medicine · doi:10.2165/00007256-200737110-00003 · Cited by 50
Enes, J. E., Wages, A. J., Malone, J. B., & Tesana, S. (2010) · PubMed · Cited by 49
Lysine 63 Polyubiquitination in Immunotherapy and in Cancer-promoting Inflammation
Martínez‐Forero, I., Rouzaut, A., Palazón, A., Dubrot, J., & Melero, I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1225 · Cited by 50
Association Between Schistosomiasis and Cancer
Palumbo, E. (2007) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000269904.90155.ce · Cited by 49
Shao, Y., Ning, Z., Chen, J., Geng, Y., Gu, W., Huang, J., Pei, H., Shen, Y., & Jiang, J. (2015) · Scientific Reports · doi:10.1038/srep18811 · Cited by 49
Microbial infection, inflammation and epithelial ovarian cancer
Xie, X., Yang, M., Ding, Y., & Chen, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6388 · Cited by 50
XRCC1 and base excision repair balance in response to nitric oxide
Mutamba, J. T., Svilar, D., Prasongtanakij, S., Wang, X., Lin, Y., Dedon, P. C., Sobol, R. W., & Engelward, B. P. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.10.008 · Cited by 48
Lunasin: A promising polypeptide for the prevention and treatment of cancer
Wan, X., Liu, H., Sun, Y., Zhang, J., Chen, X., & Chen, N. (2017) · Oncology Letters · doi:10.3892/ol.2017.6017 · Cited by 48
The silver lining: towards the responsible and limited usage of silver
Naik, K., & Kowshik, M. (2017) · Journal of Applied Microbiology · doi:10.1111/jam.13525 · Cited by 48
Clonal hematopoiesis, aging, and cardiovascular diseases
Pardali, E., Dimmeler, S., Zeiher, A. M., & Rieger, M. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.006 · Cited by 50
Anti-inflammatory peptides from enzymatic hydrolysates of tuna cooking juice
Cheng, M.-L., Wang, H.-C., Hsu, K., & Hwang, J. (2015) · Food and Agricultural Immunology · doi:10.1080/09540105.2015.1036352 · Cited by 47
Birbach, A., Eisenbarth, D., Kozakowski, N., Ladenhauf, E. M., Schmidt‐Supprian, M., & Schmid, J. A. (2011) · Neoplasia · doi:10.1593/neo.11524 · Cited by 47
Eicosanoids and Adipokines in Breast Cancer: From Molecular Mechanisms to Clinical Considerations
Basu, S., Nachat, R., Caldefie‐Chezet, F., & Vasson, M. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4408 · Cited by 47
Mutalima, N., MOLYNEUX, E. M., Johnston, W. T., Jaffe, H. W., Kamiza, S., Borgstein, E. S., Mkandawire, N. C., Liomba, G. N., Batumba, M., Carpenter, L. M., et al. (2010) · Infectious Agents and Cancer · doi:10.1186/1750-9378-5-5 · Cited by 47
Somma, F., Castagnola, R., Bollino, D. R., & Marigo, L. (2010) · PubMed · Cited by 47
Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment
Chang, S. C., & Ding, J. L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.08.002 · Cited by 47
Complex interactions between the microbiome and cancer immune therapy
Schwartz, D. J., Rebeck, O. N., & Dantas, G. A. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1660303 · Cited by 52
Correa, M., Machado, J., Carneiro, C. R. W., Pesquero, J. B., Bäder, M., Travassos, L. R., Chammas, R. J., & Jasiulionis, M. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20673 · Cited by 47
Acetamides: chemotherapeutic agents for inflammation-associated cancers
Rani, P., Pal, D., Hegde, R. R., & Hashim, S. R. (2015) · Journal of Chemotherapy · doi:10.1179/1973947815y.0000000060 · Cited by 46
Bacterial protein toxins in human cancers
Rosadi, F., Fiorentini, C., & Fabbri, A. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv105 · Cited by 46
Inflammation, Tumor Necrosis Factor and Wnt Promotion in Gastric Cancer Development
Oguma, K., Oshima, H., & Oshima, M. (2010) · Future Oncology · doi:10.2217/fon.10.13 · Cited by 46
Yatam, S., Gundla, R., Jadav, S. S., Pedavenkatagari, N. R., Chimakurthy, J., Namratha Rani, B., & Kedam, T. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.01.060 · Cited by 46
Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients
Yang, A., Li, H., Tao, W., Yang, X., Wang, M., Yang, W., & Liu, J. (2020) · Aging · doi:10.18632/aging.103255 · Cited by 45
Das, L., & Vinayak, M. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.024 · Cited by 45
IL-1/IL-1R Signaling in Head and Neck Cancer
Niklander, S. E., Murdoch, C., & Hunter, K. D. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.722676 · Cited by 43
The Four Horsemen in Colon Cancer
Hernández-Luna, M. A., López-Briones, S., & Lurı́a-Pérez, R. (2019) · Journal of Oncology · doi:10.1155/2019/5636272 · Cited by 45
Li, T., Feng, Z., Jia, S., Wang, W., Du, Z., Chen, N., & Chen, Z. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1519-x · Cited by 43
NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges
Guo, Q. H., Jin, Y., Lin, M., Zeng, C., & Zhang, J. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122684 · Cited by 51
CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis
Gao, D. F., Cazares, L. H., & Fish, E. N. (2017) · BMC Cancer · doi:10.1186/s12885-017-3817-0 · Cited by 42
Wang, M., Su, Z., & Barnie, P. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106298 · Cited by 42
Yeo, M., Park, H.-K., Lee, K.-M., Lee, K. J., Kim, J., Cho, S. W., & Hahm, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.214 · Cited by 42
Endocarditis and Risk of Cancer: A Danish Nationwide Cohort Study
Thomsen, R. W., Farkas, D. K., Friis, S., Sværke, C., Ording, A. G., Nørgaard, M., & Sørensen, H. T. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.07.026 · Cited by 41
The role of PGE2-associated inflammatory responses in gastric cancer development
Oshima, H., & Oshima, M. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0353-5 · Cited by 41
Hepatitis B among Asian Americans: Prevalence, progress, and prospects for control
Chen, M. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i42.11924 · Cited by 41
Chen, Y., Jin, M., Shao, Y., & Xu, G. (2019) · Disease Markers · doi:10.1155/2019/4659048 · Cited by 42
Functional role of bioactive peptides with special reference to cheeses
Rafiq, S., Gulzar, N., Sameen, A., Huma, N., Hayat, I., & Ijaz, R. (2020) · International Journal of Dairy Technology · doi:10.1111/1471-0307.12732 · Cited by 40
Antiviral Activity of Phytochemicals: A Current Perspective
Naithani, R., Mehta, R. G., Shukla, D., Chandersekera, S. N., & Moriarty, R. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-061-8_24 · Cited by 40
Molecular Mechanisms of H. pylori-Induced DNA Double-Strand Breaks
Kidane, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102891 · Cited by 42
Misso, R.-L. N. M., Obiang, C. S., Ndong, J. D. L. C., Ndong-Atome, G.-R., Ondo, J. P., Abessolo, F. O., & Obame-Engonga, L.-C. (2019) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2019.05.010 · Cited by 41
Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis
Silbergleit, M., Vasquez, A. A., Miller, C. J., Sun, J., & Kato, I. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.02.004 · Cited by 40
Falleti, E., Fabris, C., Toniutto, P., Fontanini, E., Cussigh, A., Bitetto, D., Fumolo, E., Fornasiere, E., Bragagnini, W., Pinato, D. J., et al. (2009) · Oncology · doi:10.1159/000260057 · Cited by 40
Parasitic Infections and Hepatic Neoplasia
Abdel-Rahim, A. Y. (2001) · Digestive Diseases · doi:10.1159/000050695 · Cited by 40
Zhao, T. M., Zhu, Y., Zhao, R., Xiong, S., Sun, J., Zhang, J., Fan, D., Deng, J., & Yang, H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106820 · Cited by 42
An Update on Helicobacter pylori as the Cause of Gastric Cancer
Zhang, W., Lü, H., & Graham, D. Y. (2014) · Gastrointestinal Tumors · doi:10.1159/000365310 · Cited by 39
Pneumocystis jiroveciicolonization in chronic pulmonary disease
Gutiérrez, S., RESPALDIZA, N., Campano, E., Martínez-Rísquez, M. T., Calderón, E. J., & de la Horra, C. (2011) · Parasite · doi:10.1051/parasite/2011182121 · Cited by 39
Seledtsov, V. I., & Seledtsova, G. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.10.011 · Cited by 38
Maggio‐Price, L., Treuting, P. M., Bielefeldt‐Ohmann, H., Seamons, A., Drivdahl, R. H., Zeng, W., Lai, L., Huycke, M. M., Phelps, S. R., Brabb, T., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080485 · Cited by 39
Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment.
Morand, S., Staats, H., Creeden, J., Iqbal, A. K., Kahaleh, B., Stanbery, L., Dworkin, L., & Nemunaitis, J. (2020) · Future Oncology · doi:10.2217/fon-2019-0722 · Cited by 30
Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
Pramanik, A., & Bhattacharyya, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120755 · Cited by 39
Ivanova, A. A., Ivanov, S. V., Pascal, V., Lumsden, J. M., Ward, J., Morris, N. L., Tessarollo, L., Anderson, S. K., & Lerman, M. I. (2007) · The Journal of Pathology · doi:10.1002/path.2146 · Cited by 39
Immature myeloid-derived suppressor cells: A bridge between inflammation and cancer
Musolino, C., Allegra, A., Pioggia, G., & Gangemi, S. (2016) · Oncology Reports · doi:10.3892/or.2016.5291 · Cited by 41
Wang, L., Qin, X., Zhang, Y., Xue, S., & Song, X. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1006233 · Cited by 39
Hu, J., Jo, M., Eastman, B. M., Gilder, A. S., Bui, J. D., & Gonias, S. L. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.003 · Cited by 38
Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
Gong, Z., Ma, J., Su, H., Guo, T., Cai, H., Chen, Q., Zhao, X., Qi, J., & Du, J. (2018) · International Journal of Clinical Oncology · doi:10.1007/s10147-018-1242-2 · Cited by 38
Huang, X., Pan, T. S., Yan, L., Jin, T., Zhang, R., Chen, B., Feng, J., Duan, T., Yu, X., Zhang, M., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.002 · Cited by 42
Marwaha, V., Chen, Y., Helms, E., Arad, S., Inoue, H., Bord, E., Kishore, R., Sarkissian, R. D., Gilchrest, B. A., & Goukassian, D. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503245200 · Cited by 37
Cost of screening and treatment of cervical dyskaryosis in Germany.
Ku, P., Breugelmans, J. G., Bénard, S., Lamure, E., Littlewood, K., & Hillemanns, P. (2008) · PubMed · Cited by 38
Li, Z., Zhong, W.-F., Lv, Y., Kraus, V. B., Gao, X., Chen, P., Huang, Q., Ni, J.-D., Shi, X.-M., Mao, C., et al. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0168-5 · Cited by 37
Antiviral Potential of Selected Medicinal Herbs and Their Isolated Natural Products
Perera, W. P. R. T., Liyanage, J. A., Dissanayake, K. G. C., Gunathilaka, H., Weerakoon, T., Wanigasekara, D., Fernando, W. S. K., Rajapaksha, H., Liyanage, R., & Perera, B. T. (2021) · BioMed Research International · doi:10.1155/2021/7872406 · Cited by 37
Concomitant prostatic schistosomiasis and sdenocarcinoma: case report and review
Basílio‐de‐Oliveira, C. A., Aquino, A., Simon, E. F., & Eyer-Silva, W. D. A. (2002) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702002000100007 · Cited by 37
Lu, H., Yu, L., Liu, Q., & Du, J. (2013) · Polymer Chemistry · doi:10.1039/c3py00393k · Cited by 36
Yazdi, H. R., Movafagh, A., Fallah, F., Shargh, S. A., Mansouri, N., Pour, A. H., & Hashemi, M. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.s3.279 · Cited by 36
The significance of gene mutations across eight major cancer types
Paul, P., Malakar, A. K., & Chakraborty, S. (2019) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2019.04.004 · Cited by 36
Prognostic impact of infectious complications after curative gastric cancer surgery
Han, W. H., Oh, Y. J., Eom, B. W., Yoon, H. M., Kim, Y., & Ryu, K. W. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.04.032 · Cited by 36
Eslamijouybari, M., Heydari, K., Maleki, I., Moosazadeh, M., Hedayatizadeh‐Omran, A., Vahedi, L., Ghasemian, R., Sharifpour, A., & Alizadeh‐Navaei, R. (2020) · Europe PMC (PubMed Central) · doi:10.22088/cjim.11.0.531 · Cited by 37
Metadata
- Authors
- Kuper, H., Adami, H. ‐., & Trichopoulos, D.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 248
- Issue
- 3
- Pages
- 171-183
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2159454395
- Cited by
- 740
- References
- 109
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 23 · 2023: 44 · 2022: 29 · 2021: 39 · 2020: 36 · 2019: 42 · 2018: 32 · 2017: 41 · 2016: 35 · 2015: 37 · 2014: 32 · 2013: 44 · 2012: 30
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- infection, cancer prevention, carcinogenesis, chronic inflammation, oncogenes, tumour suppressor, immunosuppression, persistent infection, tumor latency
- MeSH terms
- Animals, Clonorchiasis, Humans, Neoplasms, Primary Prevention, Schistosomiasis, Virus Diseases, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
